Goldman Sachs (NYSE: GS) has faced its share of challenges in recent years, primarily stemming from a slowdown in capital ...

More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...

Goldman Sachs would consider acquisitions in asset and wealth management, but the bar for doing a deal is very high, CEO ...

The companies that make up the Standard & Poor’s 500 stock index this year will collectively increase earnings per share by ...

Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...

Goldman Sachs raised M&M's target price to Rs 3,800, citing strong tractor demand. Shares hit an all-time high of Rs 3,276.30 ...

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...

Alongside record profits, USDT issuer Tether also reported Friday it now holds over $143 billion in reserve assets to back ...

Ford reported fourth-quarter 2024 revenue and adjusted earnings per share of $48.2 billion and $0.39, respectively, ...